Cite
HARVARD Citation
Funakoshi, Y. et al. (2021). Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. Cancer medicine. pp. 3177-3187. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Funakoshi, Y. et al. (2021). Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma. Cancer medicine. pp. 3177-3187. [Online].